Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

University of California, Oakland divulges UT-A inhibitors

Nov. 26, 2015

BTK inhibition, a potential strategy for the treatment of lupus nephritis

Nov. 26, 2015

Angion's CYP11B2 inhibitor shows potential for CKD in animal models

Nov. 25, 2015

FDA grants orphan drug designation to Amyndas Pharmaceuticals' Compstatin 40

Nov. 18, 2015

ProMetic reveals agent under development for diabetic nephropathy

Nov. 18, 2015

Sophiris Bio reports results from phase III trial of PRX-302 in BPH

Nov. 13, 2015

Antagonism of CCR2/5 in type 2 diabetic nephropathy

Nov. 9, 2015

SUL-121, a novel candidate to treat diabetic nephropathy

Nov. 9, 2015

Preclinical toxicity study results for Pyridorin will support planned IND filing

Nov. 9, 2015

Quark Pharmaceuticals plans new trials of QPI-1002

Nov. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...